Concepedia

Levi Mangarin

LM

Statistics

Publications

9

Citations

2.1K

H-Index

9

Active since

2018

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

Memorial Sloan Kettering Cancer Center

Swim Across America

Cornell University

Icahn School of Medicine at Mount Sinai

Levi Mangarin is an author at Parker Institute for Cancer Immunotherapy specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2018–2024

9

Publications

9

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi et al. · Cancer Cell · 2018 · 1.2K citations · Full text

, , +17

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Luís Felipe Campesato, Sadna Budhu, Jeremy H. Tchaicha et al. · Nature Communications · 2020 · 466 citations · Full text

, , +17

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy

Jacob Ricca, Anton Oseledchyk, Tyler Walther et al. · Molecular Therapy · 2018 · 147 citations · Full text

, , +17

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

Andrew Chow, Fathema Uddin, Michael Liu et al. · Immunity · 2022 · 126 citations · Full text

, , +17

Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models

Svena Verma, Sadna Budhu, Inna Serganova et al. · Journal of Clinical Investigation · 2024 · 72 citations · Full text

, , +17

1–5 of 9